Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Research institute in Jacksonville, Florida
4085 University Blvd S #1, Jacksonville, FL 32216
About Jacksonville Center for Clinical Research
"We are a member site of ENCORE Research Group, a premier clinical research organization that has conducted more than 2,500 clinical trials over 20 years and has worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
32
Eli Lilly and Company
11
AstraZeneca
6
Bristol-Myers Squibb
6
Amgen
4
Gilead Sciences
4
Hoffmann-La Roche
4
Takeda
4
BioCryst Pharmaceuticals
3
Biogen
3
Boehringer Ingelheim
3
Clinical Trials at Jacksonville Center for Clinical Research
During the past decade, Jacksonville Center for Clinical Research conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 79 clinical trials were completed, i.e. on
average, 91.9% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 39 clinical trials were completed. i.e. 125.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
2001-12-01
2003-05-01
Completed
230
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
2000-12-01
2004-01-01
Completed
431
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
2000-09-01
2003-10-01
Completed
446
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
2002-06-01
Terminated
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
2002-08-01
2003-05-01
Completed
156
Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
2002-01-01
Completed
3,000
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
2002-08-01
2003-08-01
Completed
204
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jacksonville Center for Clinical Research" #1 sponsor was "Pfizer" with 32 trials, followed by "Eli Lilly and Company" with 11 trials
sponsored, "AstraZeneca" with 6 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored and "Amgen"
with 6 trials sponsored. Other sponsors include 138 different institutions and
companies that sponsored additional 100 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jacksonville Center for Clinical Research"
#1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Cardiokine Biopharma, LLC" with 2 trials as a collaborator and "Integrium" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were
collaborators in the rest 36 trials.
Clinical Trials Conditions at Jacksonville Center for Clinical Research
According to Clinical.Site data, the most researched conditions in "Jacksonville Center for Clinical Research" are
"Alzheimer Disease" (7 trials), "Alzheimer's Disease" (7 trials), "Hypertension" (7 trials), "Heart Failure" (6 trials) and "Influenza" (6 trials). Many other conditions were trialed in "Jacksonville Center for Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Jacksonville Center for Clinical Research
Most popular intervention types in "Jacksonville Center for Clinical Research" are "Drug" (166 trials), "Biological" (24 trials), "Device" (16 trials), "Other" (16 trials) and "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (87 trials), "placebo" (9 trials), "Donanemab" (4 trials), "Naproxen" (4 trials) and "Apixaban" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Jacksonville Center for Clinical Research
The vast majority of trials in "Jacksonville Center for Clinical Research" are
193 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Jacksonville Center for Clinical Research
Currently, there are NaN active trials in "Jacksonville Center for Clinical Research".
undefined are not yet recruiting,
13 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 141 completed trials in Jacksonville Center for Clinical Research,
1 suspended trials,
and 28 terminated clinical trials to date.
Out of the total trials that were conducted in Jacksonville Center for Clinical Research, 12 "Phase 1"
clinical trials were conducted, 64 "Phase 2" clinical
trials and 105 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 14 trials, and there were
also 10 trials that are defined as “Not Applicable".